C2Dx, Inc.

C2Dx is a legitimate, verified medical device company with estimated annual revenue of ~$19M and 70+ employees, significantly exceeding the traction implied by the low-quality submission. The company acquires and revitalizes legacy medical products (e.g., Stryker T/Pump, Hemostatix Scalpel), demonstrating high real-world utility and strong market positioning. However, the submission itself contained hallucinations (claiming 'everyone' as the audience and 'most people' as users) and lacked specific data, resulting in severe penalties to the Response Quality and Quality Factors. The final score reflects the high verified value of the business heavily discounted by the poor quality of the application data.